Shares of Edgewise Therapeutics, Inc. (EWTX) have gained 14.4% over the past four weeks to close the last trading session at $14.89, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$40.90 indicates a potential upside of 174.7%.The average comprises 10 short-term price targets ranging from a low of $14 to a high of$52, with a standard deviation of $14.28. While the lowest estima ...